STEMI
Clinical trials for STEMI explained in plain language.
Never miss a new study
Get alerted when new STEMI trials appear
Sign up with your email to follow new studies for STEMI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Balloon over stent? new heart attack treatment tested
Disease control Recruiting nowThis study tests using a drug-coated balloon instead of a permanent stent to open blocked arteries during a heart attack. The balloon delivers medication to prevent re-blockage without leaving a metal implant. Researchers will track 300 participants to see if this approach is saf…
Matched conditions: STEMI
Sponsor: Medical University of Vienna • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a common diabetes pill prevent heart failure after a heart attack?
Disease control Recruiting nowThis study tests whether dapagliflozin, a drug already used for diabetes and heart failure, can help the heart heal better after a heart attack. About 450 adults who have had a heart attack and have weak heart pumping will receive either the drug or a placebo for 6 months. The go…
Matched conditions: STEMI
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a quick Beta-Blocker shot save more heart muscle?
Knowledge-focused Recruiting nowThis study looks at whether giving the beta-blocker landiolol early, during a heart attack, can reduce the amount of heart muscle that dies. It will follow 100 patients who get either landiolol or a standard oral beta-blocker, based on their doctor's choice. The main goal is to m…
Matched conditions: STEMI
Sponsor: Aristotle University Of Thessaloniki • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Blood test may reveal hidden danger after heart attack
Knowledge-focused Recruiting nowThis study looks at 1,600 people who recently had a heart attack to see if a common blood test (the neutrophil-to-lymphocyte ratio, or NLR) can help predict who is at higher risk of dying or having another heart problem within 6 months. Researchers will measure NLR from blood sam…
Matched conditions: STEMI
Sponsor: University Hospital Centre Mother Teresa • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC